SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-17-005594
Filing Date
2017-08-01
Accepted
2017-08-01 16:06:01
Documents
4
Period of Report
2017-07-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 40181
2 EX-10.1 ex-10d1.htm EX-10.1 245118
3 EX-10.2 ex-10d2.htm EX-10.2 107154
4 EX-10.3 ex-10d3.htm EX-10.3 100887
  Complete submission text file 0001558370-17-005594.txt   494553
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 17996773
SIC: 2834 Pharmaceutical Preparations